ShravantiMacherlaMD

Hematology • Gainesville, GA

Clotting Disorder, Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Physician

Join to view full profile

Dr. Macherla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Macherla's full profile

Already have an account?

Office
725 Jesse Jewell Parkway Southeast
Gainesville, GA 30501
Phone+1 770-297-5700
Is this information wrong?

Education & Training

Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2020
Osmania Medical College NTR UHSClass of 2008
Robert Packer Hospital/GuthrieResidency, Internal Medicine

Certifications & Licensure

GA State Medical License 2020 - 2025
NC State Medical License 2014 - 2021
PA State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

3 citations
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistanc...
Abdul Rafeh Naqash, Justin D McCallen, Emma Mi, Sanna Iivanainen, Mona A Marie, Daria Gramenitskaya, James Clark, Jussi Pekka Koivunen, Shravanti Macherla, Sweta Jonna...> ;Journal for Immunotherapy of Cancer. 2023 Oct 1
1 citations
A Case of Warm Autoimmune Hemolytic Anemia Secondary to Epstein-Barr Virus Infection.
Oluseyi Abidoye, Comfort Adewunmi, Shravanti Macherla> ;Cureus. 2022 Jun 1
66 citations
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort ...
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;JAMA Oncology. 2021 Nov 4
12 citations
Association of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non-small cell lung cancer
Kartik Sehgal, Anushi Bulumulle, Heather Brody, Ritu R. Gill, Shravanti Macherla, Aleksandra Qilleri, Danielle C. McDonald, Cynthia R. Cherry, Meghan Shea, Mark S. Hub...> ;Clinical Lung Cancer. 2021 May 1
15 citations
Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC.
Biagio Ricciuti, Abdul Rafeh Naqash, Jarushka Naidoo, Kartik Sehgal, Adam Miller, Kenneth L. Kehl, Deepti Venkatraman, Jacob Sands, Giuseppe Lamberti, Gonzalo Recondo,...> ;JTO Clinical and Research Reports. 2020 Nov 1
25 citations
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition
Abdul Rafeh Naqash, Ebenezer Ofori Appah, Li V. Yang, Mahvish Muzaffar, Mona A. Marie, Justin D. McCallen, Shravanti Macherla, Darla K. Liles, Paul R. Walker> ;Journal for Immunotherapy of Cancer. 2019 Jul 5
60 citations
Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer.
Shravanti Macherla, Shachar Laks, Abdul Rafeh Naqash, Anushi Bulumulle, Emmanuel E. Zervos, Mahvish Muzaffar> ;International Journal of Molecular Sciences. 2018 Nov 7
Join now to see all

Hospital Affiliations

Northeast Georgia Medical Center BraseltonBraselton, Georgia
Northeast Georgia Medical CenterGainesville, Georgia
ECU Health Medical CenterGreenville, North Carolina